Calling all who are interested in pushing the frontiers of medicine through engineering! Whether you are interested in cell therapies or genetic engineering, the Penn Healthcare Review’s Journal Event is for you! This will be a 2-part event that will consist of an hour of Q&A with distinguished panelists and an hour of catered dinner. 

Our guest speakers are Dr. Carl June, Dr. Drew Weissman, and Dr. Bruce Levine, three scientists that have significantly changed the paradigm of medicine through cell and gene therapies. We explored these topics and many more in our Journal, one that we will share with the rest of the Penn community at this event. We hope to see you there!

	Human colorectal cancer cells treated with a topoisomerase inhibitor and an inhibitor of the protein kinase ATR (ataxia telangiectasia and Rad3 related), a drug combination under study as a cancer therapy. Cell nuclei are stained blue; the chromosomal protein histone gamma-H2AX marks DNA damage in red and foci of DNA replication in green.  Created by Yves Pommier, Rozenn Josse, 2014

PHR Launch: The Future of Cell & Gene Therapy

Restricted Access

Photo Album

Activity